Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Sign up freePricing

Merck Ventures B.V. investment portfolio

Merck Ventures B.V. has made numerous investments in companies such as Storm Therapeutics, Enara Bio, and Labgenius within the Biotech sector.

vc
Portfolio
8
Team
0

Portfolio (8)

CompanySectorSourceLast confirmed on
Artios Pharma LimitedHealthcare & Life SciencesConfirmed2025-12-28
Enara Bio Limited
Enara Bio Limited is a biopharmaceutical company that discovers "Dark Antigens" from genomic dark matter to develop T-cell receptor-based therapies and bispecific T-cell engagers. These immunotherapies are designed to treat broad populations of patients with solid tumors, including lung, breast, and gastrointestinal cancers.
BiotechHealth Tech
Confirmed2025-11-07

Sign up to see the full portfolio

+6 more companies

Sign up

Shareholding changes (12)

Merck Ventures B.V.'s positions across portfolio companies
2025

Sign up free to see when this investor has bought or sold shares.

+10 more changes

Sign up

Articles (2)